The Patent Finder

Jones Pharma Incorporated

Also on record
Records under this name other than patents Jones Pharma Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Jones Pharma Incorporated

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,714,006Methods of modifying the bioavailability of metaxalone
Formerly held
Term ended
Term ended Jan 14, 2025 · USPTO record
Term endedTerm ended Jan 14, 2025USPTO record
US 7,005,416Dalfopristine/Quinupristine Combinations with Cefpirome
Formerly held
Term ended
Term ended Aug 10, 2022 · High confidence
Term endedTerm ended Aug 10, 2022High confidence
US 6,555,581Levothyroxine compositions and methods
Formerly held
Term ended
Term ended Feb 15, 2022 · USPTO record
Term endedTerm ended Feb 15, 2022USPTO record
US 6,407,128Method for increasing the bioavailability of metaxalone
Formerly held
Term ended
Term ended Dec 3, 2021 · USPTO record
Term endedTerm ended Dec 3, 2021USPTO record
US 6,683,102Methods of using metaxalone in the treatment of musculoskeletal conditions
Formerly held
Term ended
Term ended Dec 3, 2021 · USPTO record
Term endedTerm ended Dec 3, 2021USPTO record
US 6,187,746Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
Formerly held
Term ended
Term ended Dec 15, 2018 · USPTO record
Term endedTerm ended Dec 15, 2018USPTO record
US 4,626,538[7-(3-Disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
Term ended
Term ended no later than Dec 2, 2006 · Low confidence
Term endedTerm ended no later than Dec 2, 2006Low confidence
US 5,714,607Process improvement in the synthesis of N-3-(3-cyano-pyrazolo1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
Formerly held
Term ended
Term ended no later than Feb 3, 2018 · Low confidence
Term endedTerm ended no later than Feb 3, 2018Low confidence
US 5,994,338Stabilized pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
Formerly held
Term ended
Term ended no later than Nov 30, 2019 · Low confidence
Term endedTerm ended no later than Nov 30, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited